ENOV
ENOV
US1940145022
Enovis Corporation
Loading chart...

Company Profile

Enovis Corporation, a medical technology company, focuses on developing clinically differentiated solutions in the United States and internationally. It operates through two segments: Prevention and Recovery, and Reconstructive segments. The Prevention and Recovery segment offers rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, electrical stimulators for pain management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions. The Reconstructive segment develops, manufactures, markets, and distributes surgical solutions that restore mobility and improve patient outcomes, which includes a range of differentiated implants, instrumentation, and enabling technologies used in elective and non-elective joint replacement, limb reconstruction, and foot and ankle procedures; and products for the hip, knee, shoulder, elbow, extremity reconstruction and fixation, foot, ankle, and finger, as well as surgical productivity tools. It also manufactures and distributes a range of products which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company distributes its products through independent distributors, direct salespeople, and patients. The company was formerly known as Colfax Corporation. Enovis Corporation was founded in 1995 and is headquartered in Lewisville, Texas.

Latest News

Related stocks

LMRI
LMRI • United States
Lumexa Imaging Holdings, Inc.
10.54 USD
1.01B USD
BBNX
BBNX • United States
Beta Bionics, Inc.
17.63 USD
951.07M USD 1Y -21.2%
CBLL
CBLL • United States
CeriBell, Inc.
23.63 USD
906.87M USD 1Y +89.1%
AVNS
AVNS • United States
Avanos Medical, Inc.
24.99 USD
1.17B USD
AHCO
AHCO • United States
AdaptHealth Corp.
6.06 USD
824.49M USD 1Y -32.3%
TNDM
TNDM • United States
Tandem Diabetes Care, Inc.
16.11 USD
1.12B USD 1Y +2.2%
AORT
AORT • United States
Artivion, Inc.
21.26 USD
1.04B USD 1Y -48.3%
IART
IART • United States
Integra LifeSciences Holdings C
13.44 USD
1.05B USD 1Y -9.5%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
42.9% p.a.
Max Drawdown (5Y)
-80.9%
Sharpe Ratio (5Y)
-0.68
Beta Factor
1.48
Size Class
Small Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Unprofitable business model: The company is currently generating net losses.
Elevated Short-Term Volatility: 3Y volatility (48.7%) is noticeably higher than the 5Y average (42.9%).
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (42.9% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -80.9% in the extended horizon.
ende